康斯特:SpaceX在2016年-2024年各年度采购的校准测试产品订单金额较小

Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of 30.78% over several trading days in 2025, indicating unusual volatility [1] Group 1: Company Performance - The company's main business involves calibration testing instruments, which account for 95% of its revenue [1] - More than 50% of the company's revenue comes from international markets [1] - The impact of procurement orders from high-end manufacturing client SpaceX between 2016 and 2024 is limited due to the small order amounts [1] Group 2: Operational Status - The company is operating normally, with no changes in internal or external environments reported [1] - There are no undisclosed significant matters from the controlling shareholder and actual controller [1] - During the period of abnormal stock price fluctuation, there were no transactions involving the company's stock [1]